Funduscopic and angiographic appearance in the neuronal ceroid lipofuscinoses

Retina

Volumn 29, Issue 5, 2009, Pages 657-668

  Hainsworth, Dean P ^a,b   Liu, Grace T ^a   Hamm, Charles W ^a   Katz, Martin L ^a  

^a University of Missouri   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; EPIRETINAL MEMBRANE; EYE EXAMINATION; FEMALE; FLUORESCENCE ANGIOGRAPHY; HETEROZYGOTE DETECTION; HUMAN; MALE; NEURONAL CEROID LIPOFUSCINOSIS; OPHTHALMOSCOPY; OUTCOME ASSESSMENT; PIGMENT EPITHELIUM; SCHOOL CHILD; AGED; ATROPHY; DIFFERENTIAL DIAGNOSIS; GENETICS; HETEROZYGOTE; MIDDLE AGED; PATHOLOGY; PHOTOGRAPHY; PRESCHOOL CHILD; RETINA DISEASE;

ADOLESCENT; ADULT; AGED; ATROPHY; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; EPIRETINAL MEMBRANE; FEMALE; FLUORESCEIN ANGIOGRAPHY; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; NEURONAL CEROID-LIPOFUSCINOSES; OPHTHALMOSCOPY; PHOTOGRAPHY; RETINAL DISEASES; RETINAL PIGMENT EPITHELIUM; YOUNG ADULT;

EID: 66349091977     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31819b0542     Document Type: Article

References (24)

1. Wisniewski KE, Rapin I, Heaney-Kieras J. Clinico-pathological variability in the childhood neuronal ceroid-lipofuscinoses and new observations on glycoprotein abnormalities. Am J Med Genet Supplement 1988;5:27-46.
2. Wisniewski K, Zhong N. Batten Disease: Diagnosis, Treatment, and Research. New York, NY: Academic Press; 2001.
3. Wisniewski KE, Kida E, Golabek AA, Kaczmarski W, Con-nell F, Zhong N. Neuronal ceroid lipofuscinoses: classification and diagnosis. In: Wisniewski KE, Zhong N, eds. Batten Disease: Diagnosis, Treatment, and Research. New York, NY: Academic Press; 2001:1-34.
4. Warburg M. The natural history of Jansky-Bielschowsky's and Batten's disease. In: Armstrong D, Koppang N, Rider J, eds. Ceroid-lipofuscinosis (Batten's Disease). Amsterdam: Elsevier Biomedical Press; 1982:35-44.
5. Horiguchi M, Miyake Y. Batten disease; deteriorating course of ocular findings. Jpn J Ophthalmol 1992;36:91-96.
6. Henry J, Stevens S. Neuronal ceroid lipofuscinosis in the amaurotic retardate: electron microscopic confirmation. Aust J Ophthalmol 1982;10:161-166.
7. Weleber R. The dystrophic retina in multisystem disorders: the electroretinogram in neuronal ceroid lipofuscinoses. Eye 1998; 12:580-590.
8. Raitta C, Santavuori P. Ophthalmological findings in infantile type of so-called neuronal ceroid lipofuscinosis. Acta Ophthal-mol 1973;51:755-763.
9. Eksandh L, Ponjavic V, Munroe P, et al. Full-field ERG in patients with Batten/Spielmeyer-Vogt disease caused by mutations in the CLN3 gene. Ophthalmic Genet 2000;21:69-77.
10. Bateman J, Philippart M. Ocular features of the Hagberg-Santavuori syndrome. Am J Ophthalmol 1986;102:262-271.
11. Weleber R, Gupta N, Trzupek K, Wepner M, Kurz D, Milam A. Electroretinographic and clinicopathologic correlations of retinal dysfunction in infantile neuronal ceroid lipofuscinosis (infantile Batten disease). Mol Genet Metab 2004;83:128-137.
12. Seeliger M, Ruther K, Apfelstedt-Sylla E, Schlote W, Wohlrab M, Zrenner E. Juvenile neuronale zeroid-lipofuszinose (Bat-ten-Mayou); augenarztliche diagnostik und befunde. Ophthal-mologe 1997;94:557-562.
13. De Venecia G, Shapiro M. Neuronal ceroid lipofuscinosis; a retinal trypsin digest study. Ophthalmology 1984;91:1406-1410.
14. Lee C, Bang H, Oh Y, Yun H, Kim J, Coe C. A case of late infantile neuronal ceroid lipofuscinosis. Yonsei Med J 2003; 44:331-335.
15. Spalton D, Taylor D, Sanders M. Juvenile Batten's disease: an ophthalmological assessment of 26 patients. Br J Ophthalmol 1980;64:726-732.
16. Katz ML, Johnson GS, Tullis GE, Lei B. Phenotypic Characterization of a Mouse Model of Juvenile Neuronal Ceroid Lipofuscinosis. Neurobiol Dis 2008;29:242-253.
17. Steiner R, Koch T, Al-Uzri A, et al. A phase 1 clinical study of human CNS stem cells (HuCNS-SC) in patients with neuronal ceroid lipofuscinosis. In: Pearce D, Jalanki A, eds. 11th International Congress on Neuronal Ceroid Lipofuscinosis. Rochester, NY; 2007:O3.
18. Crystal RG. Adeno-associated viral-mediated gene therapy for the CNS manifestations of Batten disease. In: Pearce D, Jalanko A, eds. 11th International Congress on Neuronal Ceroid Lipofuscinosis (Batten Disease). Rochester, NY; 2007:O4.
19. Heim P, Kohlschutter A. Avoid diagnostic delay of late infantile and juvenile neuronal ceroid-lipofuscinosis (LINCL, JNCL): a word to pediatricians, neurologists, and ophthalmologists. Am J Med Genet 1995;57:238.
20. Goebel HH, Wisniewski KE. Current state of clinical and morphological features in human NCL. Brain Pathol 2004;14: 61-69.
21. Siintola E, Partanen S, Stromme P, et al. Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis. Brain 2006;129:1438-1445.
22. Siintola E, Topcu M, Aula N, et al. The novel neuronal ceroid lipofuscinosis gene MFSD8 encodes a putative lysosomal transporter. Am J Hum Genet 2007;81:136-146.
23. Steinfeld R, Reinhardt K, Schreiber K, et al. Cathepsin D deficiency is associated with a human neurodegenerative disorder. Am J Hum Genet 2006;78:988-998.
24. Bensaoula T, Shibuya H, Katz M, et al. Histopathologic and immunocytochemical analysis of the retina and ocular tissues in Batten disease. Ophthalmology 2000;107:1746-1753.